What is Advanced Pharma?
Advanced Pharma operates as a premier clinical research facility, specializing in both early and late-phase studies. With over five decades of combined Phase I expertise, the Miami-based entity has successfully executed more than 150 clinical trials. The company focuses on delivering high-quality research across Phases I through IV, guided by experienced Physician Investigators. Advanced Pharma enhances its capabilities in liver-related research and pharmaceutical development through advanced services like onsite FibroScan for liver diagnostics, ensuring a respectful and positive experience for study participants.
How much funding has Advanced Pharma raised?
Advanced Pharma has raised a total of $429K across 2 funding rounds:
Debt
$150K
Debt
$279K
Debt (2020): $150K with participation from PPP
Debt (2021): $279K led by PPP
What's next for Advanced Pharma?
The substantial large-scale late-stage funding indicates Advanced Pharma is poised for significant growth and operational scaling. This strategic investment will likely fuel the expansion of its research infrastructure, potentially enabling the initiation of more complex and extensive clinical trials. The company's focus on high-quality research and its specialized diagnostic capabilities position it for continued leadership in pharmaceutical development and clinical investigation.
See full Advanced Pharma company page
